Lung Cancer Clinical Trials in Denver

Showing 641-660 of 667 trials

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

NCT00065429

This study was a Phase I/II trial primarily focused on efficacy of BB-10901 in relapsed small cell lung cancer and other solid tumors.

Small Cell Lung Cancer

ImmunoGen, Inc.64 participantsStarted Apr 2003

Denver, Colorado, United States • Ocoee, Florida, United States • Springfield, Massachusetts, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

NCT00050960

This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.

Non-small Cell Lung Cancer

Eisai Inc.612 participantsStarted May 2002

Montgomery, Alabama, United States • Tucson, Arizona, United States • Concord, California, United States +151 more locations

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Lung Cancer Trials in Other Cities

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Study of XL281 in Adults With Solid Tumors

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Other Conditions in Denver